Quantitative Documentation of a Premenstrual Flare of Facial Acne in Adult Women

Archives of Dermatology

Volumn 140, Issue 4, 2004, Pages 423-424

  Lucky, Anne W ^a  

^a Dermatology Research Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACNE; ADULT; ARTICLE; CLINICAL ARTICLE; COMEDO; FEMALE; FOLLICULAR PHASE; HUMAN; INFLAMMATION; LUTEAL PHASE; MENSTRUAL CYCLE; PRIORITY JOURNAL;

ACNE VULGARIS; ADOLESCENT; ADULT; AGE DISTRIBUTION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MENSTRUAL CYCLE; PERIODICITY; PREMENSTRUAL SYNDROME; RISK ASSESSMENT; SAMPLING STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 1842787090     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.140.4.423     Document Type: Article

References (7)

1. Williams M, Cunliffe WJ. Explanation of premenstrual acne. LanceL 1973;2:1055-1057.
2. Cunliffe WJ. Acne. Chicago, III: Yearbook Medical Publishers: 1989:228-230.
3. Kligman AM. Postadolescent acne in women. Cutis. 1991;48:75-77.
4. Fisher DA. Desideratum dermatologicum-cause and control of premenstrual acne flare. Int J Dermatol. 2000;39:334-336.
5. Stoll S, Shalita AR, Webster GF, Kaplan R, Danesh S, Penstein A. The effect of the menstrual cycle on acne. J Am Acad Dermatol. 2001;45:957-960.
6. Lucky AW, Henderson, TA, Olson WH, Robisch DM, Lebwohl M, Swinyer LJ. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris. J Am Acad Dermatol. 1997;37:746-754.
7. Shaw JC. Low dose adjunctive spironolactone in the treatment of acne in women: a retrospective analysis of 85 consecutively treated patients. J Am Acad Dermatol. 2000;43:498-502.